HOME | SynapCell

GIVE YOUR LEADS
A TOTAL NEW PERSPECTIVE
>discover how

SynapCell is a preclinical stage biotechnology company
focused on Central Nervous System (CNS) disorders

Epilepsy
Programs
AED efficacy evaluation
using predictive EEG biomarkers and models of epilepsy
Cognitive
Programs
Accurate identification
of defects in information processing
Movement
Programs
Non behavior-related measures
of motor dysfunction within the brain

STOP GUESSING

We reveal the therapeutic potential
of pharmaceutical compounds in vivo following clinical protocols.
Since 2005, our predictive decision-making assays help our clients worldwide
clear their path to clinical success.



News & Events

Neuroscience 2017

Washington, DC | Nov 11-15 2017

ECNP 2017

Paris, France | Sep 2-5 2017

A Word about AED Trials

Miami, USA | June 2017

AED TRIALS XIV

Miami, USA | May 17-19 2017

SynapCell at AD/PD 2017

Vienna, Austria | March 29 - April 2, 2017

SynapCell selected as key partner of the ETSP

Grenoble and Salt Lake City | 03/11/2016

Neuroscience 2016

San Diego, USA | 12 - 16 NOV 2016

EILAT XIII Conference: Attending?

Madrid, Spain | 26 - 29 June 2016

MDS 2016 - Let's meet in Berlin!

Berlin, Germany | 19 - 23 June 2016

A word about Neuroscience 2015

Chicago | 17 - 21 October 2015

Neuroscience 2015 - Stop guessing

Chicago | 17 - 21 October 2015